Polymeric nanoparticle-based delivery of TRAIL DNA for cancer-specific killing

Area of Science:

• Biomaterials Science
• Nanomedicine
• Cancer Biology

Background:

• Cancer therapeutics often lack specificity, leading to damage in healthy tissues.
• Tumor Necrosis Factor-related Apoptosis-Inducing Ligand (TRAIL) shows promise for targeted cancer cell death.
• Developing targeted delivery systems is crucial for effective cancer gene therapy.

Purpose of the Study:

• To develop and evaluate synthetic poly(beta-amino ester) (PBAE) nanoparticles for targeted cancer gene therapy.
• To assess the selective transfection of cancer cells over healthy cells using PBAE nanoparticles.
• To investigate the efficacy of TRAIL DNA delivered by PBAE nanoparticles in inducing cancer cell death.

Main Methods:

• Synthesis of poly(beta-amino ester) (PBAE) nanoparticles.
• In vitro transfection of various human cancer cell lines and healthy cells.
• Delivery of Tumor Necrosis Factor-related Apoptosis-Inducing Ligand (TRAIL) DNA via PBAE nanoparticles.
• Analysis of cell death induction and correlation with TRAIL-binding surface protein expression.

Main Results:

• PBAE nanoparticles selectively transfected cancer cells in vitro compared to healthy cells.
• PBAE nanoparticles carrying TRAIL DNA induced cell death in several human cancer cell cultures.
• Resistance to TRAIL therapy was observed in certain cell types, such as human glioblastoma (GBM).
• TRAIL-binding surface protein expression predicted cell resistance to TRAIL therapy.

Conclusions:

• Synthetic PBAE nanoparticles offer a non-viral nanomedicine approach for cancer gene therapy.
• This strategy enhances cancer specificity through biomaterial design and targeted genetic cargo.
• Understanding TRAIL receptor expression is key to predicting treatment response and optimizing TRAIL-based therapies.